Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia
Soad Alsayed Altokhy;
Abstract
Background and aim: The urokinase-type plasminogen activator
system which consists of a proteinase (the urokinase-type plasnimogen
activator, uPA), a receptor (the urokinase-type plasminogen activator
receptor uPAR or CD87) and inhibitors (PAI-1) are e
system which consists of a proteinase (the urokinase-type plasnimogen
activator, uPA), a receptor (the urokinase-type plasminogen activator
receptor uPAR or CD87) and inhibitors (PAI-1) are e
Other data
| Title | Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia | Other Titles | دور منشط مستقبلات يوروكيناز البلازمينوجينCD87في سرطان الدم النخاعي الحاد | Authors | Soad Alsayed Altokhy | Keywords | Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia | Issue Date | 2013 | Description | Background and aim: The urokinase-type plasminogen activator system which consists of a proteinase (the urokinase-type plasnimogen activator, uPA), a receptor (the urokinase-type plasminogen activator receptor uPAR or CD87) and inhibitors (PAI-1) are e |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 120517R9361.pdf | 1.17 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.